Strides Pharma Science

L24230MH1990PLC057062 · ISIN — · 1 filing, FY 2022-23 to FY 2022-23 · standalone basis basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

CategoryFY 2022-23
Plastics including packaging not filed
E-waste not filed
Hazardous waste not filed
Other waste not filed
Total reclaimed 0

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23
Recycled gelatin used as input material for manufacturing of Omega – 3 capsules (Note: There is no utilisation of re-cycled or re-used input material for 100% of the production being involved in manufacturing of pharmaceutical products. Given the criticality and volatility associated with production of pharmaceutical products, consumer health, safety, compliance with applicable laws & regulations and clinical trials, there is no scope for recycling or reusing input material.) 0.0%

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
21002 Manufacturing 100.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone basis 2023-06-30 18,54,49,55,226

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error